Literature DB >> 20472405

Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes.

Moses L Joloba1, Benson R Kidenya, David P Kateete, Fred A Katabazi, Julian K Muwanguzi, Benon B Asiimwe, Simon P Alarakol, Jessica L Nakavuma, Saralee Bajaksouzian, Anne Windau, Michael R Jacobs.   

Abstract

Although there are over 90 serotypes of Streptococcus pneumoniae, antimicrobial resistance is predominantly found in a limited number of serotypes/serogroups, namely 6, 9, 14, 19 and 23. There is no compelling mechanism to account for this restriction. We aimed to determine whether serotypes commonly associated with drug resistance have higher transformation frequencies than those that are susceptible to antimicrobial agents. An in vitro investigation of the genetic transformation frequency of drug-resistant serotypes compared with that of susceptible serotypes under the influence of synthetic competence-stimulating peptides was performed. The transforming DNA was genomic DNA carrying a Tn916-like transposon containing the mefE gene that confers resistance to erythromycin. It was observed that serotypes 6, 9, 14, 19 and 23, which are highly associated with drug resistance, do not exhibit a higher degree of transformation efficiency than other serotypes. These findings suggest that the association of serotype with drug resistance is likely due to prolonged exposure to transforming DNA resulting from longer nasopharyngeal carriage and to a greater selective pressure from antimicrobials, particularly in children. This is the first study to compare the transformation frequencies of pneumococcal clinical isolates using genomic DNA that carries the composite Tn916-like element. Copyright (c) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472405      PMCID: PMC2902549          DOI: 10.1016/j.ijantimicag.2010.03.024

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  35 in total

1.  Emergence of macrolide resistance during treatment of pneumococcal pneumonia.

Authors:  Daniel M Musher; Mark E Dowell; Virginia D Shortridge; Robert K Flamm; James H Jorgensen; Pierre Le Magueres; Kurt L Krause
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

2.  A novel, multiple drug-resistant, serotype 24F strain of Streptococcus pneumoniae that caused meningitis in patients in Naples, Italy.

Authors:  Annalisa Pantosti; Giovanni Gherardi; Marco Conte; Francesco Faella; Giordano Dicuonzo; Bernard Beall
Journal:  Clin Infect Dis       Date:  2002-06-19       Impact factor: 9.079

3.  Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.

Authors:  A Tait-Kamradt; T Davies; P C Appelbaum; F Depardieu; P Courvalin; J Petitpas; L Wondrack; A Walker; M R Jacobs; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

4.  Erythromycin resistance in invasive serotype 14 pneumococci is highly related to clonal type.

Authors:  S C Clarke; K J Scott; S M McChlery
Journal:  J Med Microbiol       Date:  2004-11       Impact factor: 2.472

5.  Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.

Authors:  Paula Cerdá Zolezzi; Leticia Millán Laplana; Carmen Rubio Calvo; Pilar Goñi Cepero; Melisa Canales Erazo; Rafael Gómez-Lus
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

6.  Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).

Authors:  D Felmingham; D J Farrell; R R Reinert; I Morrissey
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

Review 7.  Pneumococcal vaccines: an update on current strategies.

Authors:  D Bogaert; P W M Hermans; P V Adrian; H C Rümke; R de Groot
Journal:  Vaccine       Date:  2004-06-02       Impact factor: 3.641

8.  Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations.

Authors:  Stella Z Doktor; Virginia D Shortridge; Jill M Beyer; Robert K Flamm
Journal:  Diagn Microbiol Infect Dis       Date:  2004-05       Impact factor: 2.803

9.  Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae.

Authors:  Krzysztof Trzciński; Claudette M Thompson; Marc Lipsitch
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

10.  Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.

Authors:  Matthias Imöhl; Ralf René Reinert; Christina Ocklenburg; Mark van der Linden
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

View more
  7 in total

1.  Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.

Authors:  Zhenying Liu; Irving Nachamkin; Paul H Edelstein; Ebbing Lautenbach; Joshua P Metlay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  Analysis of the effects of mesoporous silica particles SBA-15 and SBA-16 in Streptococcus pneumoniae transformation process.

Authors:  Maria-Cecília Krähenbühl Amstalden; José Diogo Oliveira; Mathias Strauss; Italo Odone Mazali; Daisy Machado; Thais Holtz Theisen; Marcelo Lancellotti
Journal:  Folia Microbiol (Praha)       Date:  2018-07-14       Impact factor: 2.099

3.  A modified Janus cassette (Sweet Janus) to improve allelic replacement efficiency by high-stringency negative selection in Streptococcus pneumoniae.

Authors:  Yuan Li; Claudette M Thompson; Marc Lipsitch
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

Review 4.  Variation on a theme; an overview of the Tn916/Tn1545 family of mobile genetic elements in the oral and nasopharyngeal streptococci.

Authors:  Francesco Santoro; Morgana E Vianna; Adam P Roberts
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640

5.  Sequencing of the variable region of rpsB to discriminate between Streptococcus pneumoniae and other streptococcal species.

Authors:  Anne L Wyllie; Yvonne Pannekoek; Sandra Bovenkerk; Jody van Engelsdorp Gastelaars; Bart Ferwerda; Diederik van de Beek; Elisabeth A M Sanders; Krzysztof Trzciński; Arie van der Ende
Journal:  Open Biol       Date:  2017-09       Impact factor: 6.411

6.  Intra-Species Interactions in Streptococcus pneumoniae Biofilms.

Authors:  Carina Valente; Ana R Cruz; Adriano O Henriques; Raquel Sá-Leão
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

7.  Significant variation in transformation frequency in Streptococcus pneumoniae.

Authors:  Benjamin A Evans; Daniel E Rozen
Journal:  ISME J       Date:  2013-01-10       Impact factor: 10.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.